Search research articles
Contact Us
Filters
Showing results (141-150 of 492) with videos related to
Page
of 50
Sort By:
Journal of Clinical Pathology
|
December 11, 2008
Hormone-sensitive prostate cancer: a case of ETS gene fusion heterogeneity
G Attard, C Jameson, J Moreira, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
December 16, 2023
Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer
Ricardo Donners, Ines Figueiredo, Daniel Westaby, et al.
Cancers
|
January 11, 2022
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer
Daniel Westaby, Juan M Jimenez-Vacas, Ana Padilha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 12, 2010
All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer
F A W Coumans, C J M Doggen, G Attard, et al.
British Journal of Cancer
|
February 27, 2015
The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials
R Kumar, E Geuna, V Michalarea, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 25, 2014
AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines
M Puglisi, P Thavasu, A Stewart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2000
Metastatic extragonadal seminoma associated with cardiac transplantation
J S de Bono, J A Fraser, F Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2011
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
A W Tolcher, D I Quinn, A Ferrari, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
April 19, 2011
The CT flare response of metastatic bone disease in prostate cancer
Christina Messiou, Gary Cook, Alison H M Reid, et al.
European Urology
|
September 23, 2019
Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate Cancer
Mary-Ellen Taplin, Emmanuel S Antonarakis, Karen J Ferrante, et al.
Page
of 50
Search research articles
Search
Showing results (141-150 of 492) with videos related to
Sort By:
Page
of 50
Journal of Clinical Pathology
|
December 11, 2008
Hormone-sensitive prostate cancer: a case of ETS gene fusion heterogeneity
G Attard, C Jameson, J Moreira, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society
|
December 16, 2023
Multiparametric bone MRI targeting aides lesion selection for CT-guided sclerotic bone biopsies in metastatic castrate resistant prostate cancer
Ricardo Donners, Ines Figueiredo, Daniel Westaby, et al.
Cancers
|
January 11, 2022
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer
Daniel Westaby, Juan M Jimenez-Vacas, Ana Padilha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 12, 2010
All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer
F A W Coumans, C J M Doggen, G Attard, et al.
British Journal of Cancer
|
February 27, 2015
The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials
R Kumar, E Geuna, V Michalarea, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 25, 2014
AKT inhibition synergistically enhances growth-inhibitory effects of gefitinib and increases apoptosis in non-small cell lung cancer cell lines
M Puglisi, P Thavasu, A Stewart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2000
Metastatic extragonadal seminoma associated with cardiac transplantation
J S de Bono, J A Fraser, F Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2011
A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
A W Tolcher, D I Quinn, A Ferrari, et al.
Acta Radiologica (Stockholm, Sweden : 1987)
|
April 19, 2011
The CT flare response of metastatic bone disease in prostate cancer
Christina Messiou, Gary Cook, Alison H M Reid, et al.
European Urology
|
September 23, 2019
Androgen Receptor Modulation Optimized for Response-Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7-expressing Metastatic Castration-resistant Prostate Cancer
Mary-Ellen Taplin, Emmanuel S Antonarakis, Karen J Ferrante, et al.
Page
of 50